In addition, previous studies have shown that DDIT4 is significantly downregulated in prostate cancer cells and that the induction of DDIT4 expression can regulate MYC, which is a downstream target of the mTOR signaling pathway[76,77]. This evidence concerns the gene DDIT4 and prostate cancer.